XENE FY 2015 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$16M-45.1% YoY

Gross Profit

$13M82.3% margin

Operating Income

-$9M-60.1% margin

Net Income

-$16M-101.1% margin

EPS (Diluted)

$-1.10

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$19M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$64M

Total Liabilities

$3M

Stockholders' Equity

$61M

Cash & Equivalents

$59M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$28M	-45.1%
Gross Profit	$13M	$22M	-43.0%
Operating Income	-$9M	$11M	-184.3%
Net Income	-$16M	$13M	-221.0%